William Blair & Company’s Exact Sciences EXAS Stock Holding History

William Blair & Company’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-1,000	Closed	-$35K	–	1414
2017 Q2	$35K	Buy	+1,000	New	+$30.9K	﹤0.01%	1493
2017 Q1	–	Sell	-4,500	Closed	-$46K	–	1468
2016 Q4	$46K	Buy	+4,500	New	+$72.6K	﹤0.01%	1261

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

William Blair & Company's EXAS Position: Q1 2026 in Review

William Blair & Company sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 128,517 shares — an estimated $13.1M sold.

William Blair & Company first reported a position in EXAS in Q2 2013 and held it in 51 quarters. The position peaked at $161M in Q2 2015. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

William Blair & Company reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
William Blair & Company sold 128,517 Exact Sciences shares in Q1 2026, an estimated $13.1M.
William Blair & Company first reported a position in Exact Sciences in Q2 2013 and held it in 51 quarters.
William Blair & Company's Exact Sciences position peaked at $161M in Q2 2015.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.